Skip to Content
Merck
CN

09293

2-(3-Aminopropylamino)ethanol

≥98.0% (GC)

Synonym(s):

N-(2-Hydroxyethyl)trimethylenediamine

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

Linear Formula:
NH2CH2CH2CH2NHCH2CH2OH
CAS Number:
Molecular Weight:
118.18
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
224-718-0
Beilstein/REAXYS Number:
1734412
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

2-(3-Aminopropylamino)ethanol, ≥98.0% (GC)

InChI key

GHKSKVKCKMGRDU-UHFFFAOYSA-N

InChI

1S/C5H14N2O/c6-2-1-3-7-4-5-8/h7-8H,1-6H2

SMILES string

NCCCNCCO

assay

≥98.0% (GC)

refractive index

n20/D 1.486

bp

250-252 °C (lit.)

density

1.007 g/mL at 20 °C (lit.)

Quality Level

Gene Information

rat ... Grin2a(24409)

Other Notes

Inhibitor of the mammalian glycogen debranching enzyme; Photographic development accelerator.

pictograms

CorrosionExclamation mark

signalword

Danger

hcodes

Hazard Classifications

Eye Dam. 1 - Skin Corr. 1B - Skin Sens. 1

Storage Class

8A - Combustible corrosive hazardous materials

wgk

WGK 3

flash_point_f

296.6 °F

flash_point_c

147 °C

ppe

Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Amylo-1,6-glucosidase/4-alpha-glucanotransferase: use of reversible substrate model inhibitors to study the binding and active sites of rabbit muscle debranching enzyme.
B K Gillard et al.
Biochemistry, 16(18), 3978-3987 (1977-09-06)
Panagiotis Mastorakos et al.
Journal of controlled release : official journal of the Controlled Release Society, 262, 37-46 (2017-07-12)
The discovery of powerful genetic targets has spurred clinical development of gene therapy approaches to treat patients with malignant brain tumors. However, lack of success in the clinic has been attributed to the inability of conventional gene vectors to achieve
Stephany Y Tzeng et al.
International journal of nanomedicine, 6, 3309-3322 (2012-01-10)
Biodegradable poly(ester amine) (PEA)-based and poly(amido amine) (PAA)-based nanoparticles were developed for efficient in vitro siRNA delivery to human umbilical vein endothelial cells (HUVECs). They were screened, characterized, and compared with traditionally studied DNA-containing particles. Several of the polymeric nanoparticles
Camila G Zamboni et al.
Journal of controlled release : official journal of the Controlled Release Society, 263, 18-28 (2017-03-30)
Hepatocellular carcinoma (HCC) is the third most deadly cancer in the US, with a meager 5-year survival rate of <20%. Such unfavorable numbers are closely related to the heterogeneity of the disease and the unsatisfactory therapies currently used to manage
Antonella Mangraviti et al.
ACS nano, 9(2), 1236-1249 (2015-02-03)
Biodegradable polymeric nanoparticles have the potential to be safer alternatives to viruses for gene delivery; however, their use has been limited by poor efficacy in vivo. In this work, we synthesize and characterize polymeric gene delivery nanoparticles and evaluate their

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service